Ironwood Pharmaceuticals (IRWD) Restructuring Costs (2018 - 2021)

Ironwood Pharmaceuticals has disclosed Restructuring Costs across 4 years of filings, most recently posting -$73000.0 for Q3 2021.

• Restructuring Costs for Q3 2021 came in at -$73000.0, down 105.93% year-over-year; the trailing twelve-month figure through Sep 2021 was $14.1 million (up 1291.12% YoY), and the FY2020 annual result was $15.4 million, up 327.28% from the prior year.
• Restructuring Costs came in at -$73000.0 for Q3 2021 at Ironwood Pharmaceuticals, up from -$282000.0 in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $14.2 million in Q4 2020 to a low of -$282000.0 in Q2 2021.
• The 4-year median for Restructuring Costs is $705000.0 (2018), against an average of $2.6 million.
• Across the five-year window, Restructuring Costs plunged 107.38% in 2019 and surged 27311.54% in 2020, its largest moves.
• Ironwood Pharmaceuticals' Restructuring Costs stood at $705000.0 in 2018, then slumped by 107.38% to -$52000.0 in 2019, then soared by 27311.54% to $14.2 million in 2020, then plunged by 100.52% to -$73000.0 in 2021.
• The last three Restructuring Costs figures came in at -$73000.0 (Q3 2021), -$282000.0 (Q2 2021), and $311000.0 (Q1 2021), per Business Quant data.